Analysis and Management of Adverse Drug Reactions after Injection of Amphotericin B in AIDS Patients with Fungal Infection
- 1 Pharmacy Department/Laboratory Department of Nanning Fourth People’s Hospital, Nanning, China
- 2 Department of Infectious Diseases, Debao People’s Hospital, Debao, China
- 3 Nursing Department of Liaoning Hospital Vocational College, Shenyang, China
- 4 Department of Nursing, Graduate School, Eternal University of the Philippines, Las Pinas, Philippines
- 5 Nanning Infectious Disease Hospital Affiliated to Guangxi Medical University, Nanning, China
- 6 Guangxi AIDS Clinical Treatment Center, Nanning, China
- 7 Department of Critical Medicine, Fuzhou Second People’s Hospital, Fuzhou, China
Abstract
Objective: To understand the condition of adverse drug reactions and the treatment procedures of amphotericin B for injection in patients with AIDS complicated with fungal infection. Methods: For the research object, a retrospective analysis of adverse reactions of amphotericin B injection in 121 patients of AIDS complicated with fungal infection was reported in our hospital from October 2017 to June 2021 to observe the adverse drug reactions of patients after treatment with amphotericin B for injection, 87 cases with general degree (regarded as the general group) and 34 cases with serious degree (regarded as the serious group), and analyze the general data, medication and course of disease of the two groups for symptomatic treatment. Results: Adverse reactions such as hypokalemia, abnormal liver function, renal impairment, leucopenia and drug fever were more common in the two groups, and there were also many adverse reactions such as bone marrow suppression, rash, anemia, thrombocytopenia, nausea, vomiting, fatigue, dizziness, pruritus, angina pectoris, vertigo, abdominal pain and diarrhea. The rates of leukopenia and drug fever in general group were significantly lower than those in severe group (P < 0.05); in the dose of amphotericin B used, the rate of using 25 mg and more than 25 mg in the general group was significantly lower than that in the severe group (P < 0.05). After symptomatic treat-ment, most patients have improved, and a few are unknown or have not improved. Con-clusion: Amphotericin B for injection has great side effects and will cause different degrees of adverse drug reactions. The dose of amphotericin B for clinical treatment should be ad-justed and disposed according to the adverse reactions to avoid serious consequences.
- Hu, H.J. (2020) Development and Clinical Application of Amphotericin B Preparations. Exploration of Rational Drug Use in China, 17, 5-9.
- Yang, L., Liu, J., Jiang, Y., Wang, Y.J., Xu, X.F., Gan, Z.Q., Chen, Z.L. and Peng, F.H. (2021) Efficacy and Safety of Amphotericin B in the Treatment of Cryptococcal Meningitis with Rapid Dose Increase. Chinese Journal of Neuropsychiatry, 47, 348-354.
- Qin, D.W., Yang, M.J., Lu, P.Y. and Pan, Z.Q. (2020) The Application of Amphotericin B Rapid Escalation Therapy in AIDS Complicated with Cryptococcal Meningitis. Journal of Qiannan Nationalities Medical College, 33, 185-189.
- Xu, Z.W., Deng, W.Q. and Liu, Y.B. (2020) A Clinical Study of Amphotericin B Combined with Flucytosine and Fluconazole in the Treatment of 45 Cases of Cryptococcal Meningitis after Non-HIV Infection and Non-Organ Transplantation. Infection and Chemotherapy in China Journal, 20, 396-400.
- Zhang, X.Y. (2016) Clinical Treatment and Nursing Countermeasures of Amphotericin B for AIDS Patients with Cryptococcal Meningitis. Anti-Infective Pharmacy, 13, 1308-1310.
- Liang, X.Y., Cao, Y.D., Song, Y.Q. and Ma, J. (2021) A Case of Severe Anemia, Thrombocytopenia and Hypokalemia Caused by Amphotericin B Liposome for Injection. Practical Medicine and Clinical, 24, 646-648.
- Hu, Z.L., Wei, H.X., Chi, Y., Cheng, C., Cheng, J., Chen, C., Liu, Y. and Yang, Y.F. (2014) The Application of Amphotericin B Three-Day Boosting Therapy in AIDS Complicated with Cryptococcal Meningitis. Proceedings of the 13th National Conference on Infectious Diseases of Chinese Medical Association, Guangzhou Baiyun International Convention Center, 12-15 June 2014, 449-450.
- Huang, H.Z. and Li, Y. (2020) Analysis of the Efficacy and Safety of Amphotericin B Combined with Conventional Western Medicine in the Treatment of AIDS Complicated with Fungal Infection. Contemporary Medicine Review, 18, 137-138.
- Xie, J.P. and Zhou, L.L. (2015) Adverse Reactions and Nursing of Amphotericin B in the Treatment of Aids Complicated with Cryptococcal Meningitis. Contemporary Nurses (Mid-Journal), No. 4, 89-90.
- Zhao, J.R., Rui, S.J., Peng, G.C., Zhang, E.J. and Wang, Y. (2014) Efficacy and Safety of Voriconazole Combined with Amphotericin B in Induction Therapy for Cryptococcal Meningitis in HIV-Infected Patients. Chinese Journal of Experimental and Clinical Infectious Diseases (Electronic Edition), 8, 807-811.
- Mei, H.K., Wang, D., Bai, N., Cao, J., Tang, M.J., Jiang, X.W., Wang, J. and Wang, R. (2014) Bibliometric Analysis of Amphotericin B Nephrotoxicity. China Journal of New Drugs and Clinical Medicine, 33, 924-928.